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Abstract
Complex diseases such as obesity and type II diabetes can result from a failure in multiple organ systems including the
central nervous system and tissues involved in partitioning and disposal of nutrients. Studying the genetics of gene
expression in tissues that are involved in the development of these diseases can provide insights into how these tissues
interact within the context of disease. Expression quantitative trait locus (eQTL) studies identify mRNA expression changes
linked to proximal genetic signals (cis eQTLs) that have been shown to affect disease. Given the high impact of recent eQTL
studies, it is important to understand what role sample size and environment plays in identification of cis eQTLs. Here we
show in a genotyped obese human population that the number of cis eQTLs obey precise scaling laws as a function of
sample size in three profiled tissues, i.e. omental adipose, subcutaneous adipose and liver. Also, we show that genes (or
transcripts) with cis eQTL associations detected in a small population are detected at approximately 90% rate in the largest
population available for our study, indicating that genes with strong cis acting regulatory elements can be identified with
relatively high confidence in smaller populations. However, by increasing the sample size we allow for better detection of
weaker and more distantly located cis-regulatory elements. Yet, we determined that the number of tissue specific cis eQTLs
saturates in a modestly sized cohort while the number of cis eQTLs common to all tissues fails to reach a maximum value.
Understanding the power laws that govern the number and specificity of eQTLs detected in different tissues, will allow a
better utilization of genetics of gene expression to inform the molecular mechanism underlying complex disease traits.
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Introduction
The development of high throughput technologies that allow for
whole-genome profiling of genotypes, gene expression traits,
proteins and metabolites in multiple tissues/samples from a single
individual, can provide important clues to disease mechanisms.
We have recently shown the ability to associate genetic changes to
variations in mRNA levels in an obese population undergoing
Roux en Y Gastric bypass surgery (RYGB) [1]. Similar approaches
in all realms of biology from diabetes, obesity, cardiovascular
disease, to asthma and Crohn’s disease have proved to be very
successful in identifying new therapeutic targets [2,3,4]. In recent
years, numerous genome-scale technologies have been employed
to explore the genetics of gene expression in human cell lines and
primary tissues [2,5,6,7]. These studies have generated a vast
amount of quantitative data, providing us with a systems view of
disease mechanisms [4,8,9,10,11,12,13,14,15].
In the present study, we explored 37,585 gene expression traits
in 744 omental adipose (OA), 612 subcutaneous adipose (SA) and
569 liver samples collected from self reported Caucasian subjects
undergoing RYGB where each subject was genotyped for 650,000
SNPs. Only 393 subjects had genotyping and expression profiling
data available for all three tissues and were used in this analysis.
Given the size of the cohort and the availability of multiple tissues
from the same subject we were able to analyze the genetics of gene
expression in each tissue in an attempt to understand the laws
governing the number and tissue specificity of cis eQTLs detected.
Our main goal was to identify the power laws relating to the
number and specificity of cis eQTLs detected as a function of
sample size. Understanding these relationships will allow us to
better utilize the genetics of gene expression to inform on the
molecular mechanism underlying complex disease.
Results
DNA was extracted from liver samples and genotyped on
Illumina 650Y genotyping arrays. RNA was extracted from OA,
SA and liver samples and profiled on custom Agilent expression
arrays containing 37,585 probes for gene expression traits. 393
subjects, which are self-reported Caucasians, were included in our
analysis for which genotyping and gene expression data were
available from all three tissues [1]. Cis eQTLs were identified
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M
31using the Kruskal-Wallis non-parametric test described previously
[2]. In order to reduce the number of hypotheses tested, i.e. the
pair SNP-mRNAs, only the pair with the smallest p value in a 2
Megabase (Mb) window was retained, similar to the method used
in previously published studies [2,5]. A cis eQTL is thus the
association between a SNP and the expression levels of a
transcript, where the SNP is located within the genomic region
that spans 1 Mb upstream and downstream of the transcript’s start
site, and with a p value below the p value threshold selected to
maintain a 10% FDR. In order to avoid any confusion we will
refer to the eQTLs as the transcript rather than the SNP-transcript
pair, while an expression (e)SNP is the selected SNP associated
with the mRNA profile of a transcript.
We generated 20 sub-samples Ni i=1:20 equally spaced in the
ln(n) space (where n=|N| is the size of sample N) by randomly
removing individuals from the largest sample N20 of size n20=393
until we reached a sample of size n1=50 (see Figure 1a for the
study design and Table S1). For each sub sample we removed all
SNPs that did not exceed a minor allele frequency (MAF) of 5%
(the number of SNPs removed from the analysis for each sub
sample is summarized in the Table S1). For each tissue and each
sub-sample we then proceeded to identify the cis eQTLs and
eSNPs. The sub sample generating procedure and subsequent
analysis was repeated five times (see Figure S5).
Let Qi and Si be the set of cis eQTLs and eSNPs respectively
identified using the population sub-sample Ni with qi=|Qi| and
si=|Si| the number of unique cis eQTLs and eSNPs in each set.
We found that the number of cis eQTLs precisely obeys ﬃﬃﬃ
q
p
~b   ln(n)za (Figure 1b) for each tissue in the analysis (see
Figure S1 for a comparison of plots in normal and log-normal
space). The slopes b ðÞand intercepts a ðÞfor each tissue are
summarized in Table 1. Slopes for changes in total number of cis
eQTLs as a function of sample size in each tissue are very close in
value thus we hypothesize that the scaling laws will hold in any
analysis of tissues collected from this cohort however we believe
that slope could change if tissue samples were collected from a
different cohort. The observed intercept change when analyzing
this particular cohort, with aOAwaSAwaLis most likely a con-
sequence of tissue heterogeneity. We believe that the number of cis
eQTLs detected in cellular homogenous tissues (such as adipose)
Figure 1. Number of cis eQTLs and their link to sub sample size. a) Experimental design. Starting with 393 individuals that were successfully
gene expression profiled in all 3 tissues (in the figure legends A, B, C denote OA, SA and liver respectively) and genotyped, we selected 20 sub
samples with sizes from 50 to 393 equally spaced on the logarithmic scale such thatN15N25...5N20. For each sub sample we identified cis eQTLs
in each tissue at 10% FDR. b) Number of cis eQTLs q as function of sample size n. We plot
ﬃﬃﬃ
q
p
as a function of ln(n) and show that total number of cis
eQTLs identified in each tissue is linear in this range with
ﬃﬃﬃ
q
p
*ln(n)with R
2.0.9 (see Table 1 for linear regression coefficients). Looking at cis eQTLs
across the 3 tissues we observ a tendency to plateau for cis eQTLs that are nonoverlapping (Only A, Only B and Only C) or partially overlapping in a
pair of tissue (AB, BC and CA). No such behavior is observed for cis eQTLs common to all three tissues (ABC). c) Mean genomic distance vdw
measured in Mb between the eSNP and the transcript’s position. Common cis eQTLs (ABC.A, ABC.B and ABC.C) have vdw significantly smaller
(Mann–Whitney U test p values ,0) than any vdw computed for the nonoverlapping cis eQTLs (Only A, Only B, and Only C). d) Mean association
strengthv{log10(p)w. Overlapping cis eQTLs have on average a stronger association than any other sub set of cis eQTLs. Unique cis eQTLs (Only A,
Only B, and Only C) are weakly associated when compared to overlapping cis eQTLs (ABC).
doi:10.1371/journal.pone.0023480.g001
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explaining the differences between the intercepts in each tissue.
Similar behavior was previously noted in an Icelandic population
[2,16] with 3,048 cis eQTLs detected in adipose tissue and 2,417
in whole blood from the same individuals.
While the number of cis eQTLs in each tissue obeys the same
scaling law as described above, by looking at overlaps between cis
eQTLs across the 3 tissue we identified subsets of cis eQTLs that
behaved dramatically differently as a function of sample size. We
classified cis eQTLs in seven groups. If A denotes OA tissue, B -
SA tissue and C - liver then ‘‘Only A’’, ‘‘Only B’’, ‘‘Only C’’
represent cis eQTLs unique (i.e. nonoverlapping) in OA, SA and
liver tissues, ‘‘AB’’, ‘‘BC’’, ‘‘CA’’ represent the sets of cis eQTLs
overlapping in pair of tissues such as OA-SA, SA-liver and liver-
OA, and ‘‘ABC’’ represents the set of cis eQTLs detected in all
three tissues. By looking at the plots in Figure 1b we identified 2
qualitatively different behaviors for their set size as a function of
sample size: set sizes for partially overlapping and nonoverlapping
cis eQTLs (Only A, Only B, Only C, AB, BC and CA) show a
tendency to plateau as we increase the sample size, while the
number of overlapping cis eQTLs continues its steady increase at a
rate that will approach b ðÞidentified for single tissues as sample
size increases. Using a sliding window containing consecutive data
points a more qualitative picture can be obtained (see Figure S2).
A decrease in slope (as we slide the window from the beginning of
the plot to the end) signals a saturation tendency for the number of
cis eQTLs in the set while an increase in slope signals a further
acceleration. Using this approach we again see the 2 different
trends observed in Figure 1b, saturation in the number cis eQTLs
that are not detected (tissue specific) in all three tissues. The trend
is more pronounced for cis eQTLs overlapping across less related
tissues, such as OA-liver or SA-liver, while cis eQTLs overlapping
in OA-SA reached saturation at a much slower rate. In contrast we
didn’t detect any saturation for the cis eQTLs overlapping in all
three tissues, instead an even faster rise in their numbers as the
slope increases with an increase in sample size (Figure 1b, ABC).
Since only the number of cis eQTLs detected in all three tissues
continues to increase with an increase in sample size while partially
overlapping and non-overlapping cis eQTLs reached steady
numbers, the slope for ABC will eventually reach a maximum
value bound by b identified for a single tissue, as evident in
Figure 1b.
For each set of cis eQTLs we then investigated if d (the eSNP
position relative to the start site of the transcript) was significantly
changed with sample size (Figure 1c). On average, the cis eQTLs
overlapping all three tissues had mean distance (the average is
performed over all cis eQTLs in the set) ,d. significantly smaller
than in any other set of cis eQTLs (see Figure S4 for box-plots of
d), while the tissue specific cis eQTLs displayed the largest average
distance (the Mann–Whitney U test p values testing the difference
between these 2 sets approximates 0 for any i). At the same time
the average association strength measured as v{log10(p)w for
each set is always highest for the overlapping cis eQTLs when
compared to unique cis eQTLs (Figure 1d). This behavior has
been observed previously in both mouse [17] and human studies
[5]. One argument for this observed behavior [5] is that it’s related
to the intrinsic biology, with distal regulatory elements (regulatory
enhancers) being more cell type specific than basic regulatory
elements (characterized by those eQTLs detected in all tissues).
It has been reported that 54%, 50% and 54% of cis eQTLs in
fibroblasts, LCLs and T cells respectively will be cell type specific
[5]. However, our analysis using tissues collected from a human
cohort shows that the number of unique cis eQTLs detected
saturates quite rapidly as a function of sample size, while the total
number of cis eQTLs common to all tissues continues to increase.
Therefore, the percentage of common cis eQTLs is strongly
dependent on the sample size. For example, the percentages of cis
eQTL specific to OA, SA, and liver when the sample size is
n1=50, which is the minimum sample size we tested, are 42.8%,
38.4% and 55.9%, respectively. These percentages dramatically
decrease to 23.5%, 21.1% and 35.6%, respectively, when the
maximum sample size was tested, N20=393. Because the cis
eQTL common to all tissues show no sign of saturating, we expect
these percentages to further decrease. In contrast the number of cis
eQTLs overlapping all three tissues increased from 22.25%,
24.52% 32.19% in N1 to 40.77%, 42.86%, 48.95% in N20 in OA,
SA and liver respectively. The opposite conclusion was reached in
a previous report on fibroblasts, LCLs, and T cells likely due to
three factors: 1) sample size, 2) homogenous cell population and 3)
similarities/dissimilarities between the samples (tissues versus cells)
compared.
Although we have already characterized the number of cis
eQTLs detected as a function of sample size, a key question to
address is whether the set of cis eQTLs and eSNPs identified in a
specific tissue in smaller samples continue to be present in
subsequent analysis as the cohort size is increased. To address this
question we looked at the relative overlap between consecutive
steps and plotted the percentage of cis eQTLs overlapping in
2 consecutive steps Qi\Qiz1 jj = Qi jj . A very high rate of 90%,
with approximately same value between any consecutive steps was
observed (Figure 2a). Overlaps between cis eQTL sets relative to
the largest sub sample N20 defined as Qi\Q20 jj = Qi jj (Figure 2b)
shows that more than 90% of the cis eQTLs identified in any sub-
sample will be detected in the largest population. To gauge how
many of the cis eQTLs identified in N20 were also identified in sub
sample Ni we plotted Qi\Q20 jj = Q20 jj (Figure 2c). We found that
approximately 10% of all cis eQTLs detected from N20 were also
detected in N1 increasing to ,90% in N19 (similar plots as in
Figure 2a–c for the sets of cis eQTLs previously described in
Figure 1 can be found in Figure S3). Similar results for eSNPs are
plotted in Figure 2d–f. We observed an approximate 80% overlap
between eSNPs in consecutive steps Si\Siz1 jj = Si jj (Figure 2d),
Table 1. Extrapolated scaling laws for cis eQTLs.
Tissue Intercept(alpha) Slope (beta) R
2 Observed Calculated
OA 285.832 29.131 0.998 11,018 11,403
SA 285.284 28.591 0.998 9,874 9,639
Liver 283.237 27.531 0.999 8,278 8,358
We fit,
ﬃﬃﬃ
q
p
~b   ln(n)za where q is the number of cis eQTLs and n sample size. The results of the linear fit for each tissue are presented below. Using this model we
estimated the number of cis eQTLs detected in each tissue at maximum sample size. The calculated values approximate very well the observed numbers of cis eQTLs in
each tissue.
doi:10.1371/journal.pone.0023480.t001
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overlapping eSNPs to the N20, Si\S20 jj = Si jj (Figure 2e). The
percentage of eSNPs identified in the N20 also identified in Ni,
Si\S20 jj = S20 jj (Figure 2f), increases at a slower pace overall at the
same sample size as shown for cis eQTLs. Overall, detection of cis
eQTLs is much more robust than eSNP identification with about
90% overlap between consecutive steps for cis eQTLs and ,80%
for the eSNP. As additional evidence approximately 70% of cis
eQTL and 50% of eSNPs identified at N20 were also identified in
the largest population available (n=569 liver, n=744 OA,
n=612 SA). We anticipate that these results could reflect strong
correlation between different SNPs, each of which can equally well
act as a surrogate measure for the true causal cis-acting effect
within the linkage disequilibrium (LD) block. While this behaviour
might be considered problematic, we see that in our study a
maximum of eight different SNPs were associated to the same
transcript in the 20 different sample subsets from each tissue. We
used ADRA2B in OA (Figure S6a) and ARNT in liver as examples
(Figure S6b) to demonstrate the change in lead eSNP between
different consecutive analysis steps. These two genes were found to
have the largest number of lead eSNPs in our analysis. We believe
that this phenomenon should not have a damaging effect on
eQTL identification overall, but should be considered when
interpreting lead eSNP data for gene expression traits.
We have shown that the detection of cis-acting eQTLs obeys
precise scaling laws in each tissue investigated. One important
observation regarding replication of this effect is that the number
of cis eQTLs present in all three tissues continues to grow with an
increase in samples size while the number of tissue specific cis
eQTLs starts to plateau with increasing sample size. This result is
in contradiction to recent observations that approximately 50% of
all cis eQTLs are tissue specific. The fact that the numbers of
unique cis eQTLs are reaching a plateau could imply that we have
already found a robust (i.e. that does not change with sample size)
set of unique cis eQTLs. However if one looks at the strength of
the association we find that unique cis eSNP are more weakly
associated (higher p values) to gene expression traits than
conserved cis eQTLs (Figure 1c) leading to a contradictory
conclusion, as we would anticipate that the weaker unique cis
eQTLs should contain a larger number of false positives compared
to the set of universal and more strongly associated cis eQTLs. If
we regard the increase in sample size as a dynamic change in the
genetic information, a cis eQTL can be thought of as being
created and then moving in the space between the 3 tissues, i.e.
becoming detected in a pair of tissues or detected in all 3 tissues as
well as being destroyed in the process of increasing sample size. In
Figure 3a we plot a cis eQTL as it progresses from sub sample to
sub sample. It is evident that an eQTLs can be viewed as a
‘‘dynamic’’ entity that undergoes transitions with regard to its
tissue of origin. We hypothesize that an eQTL’s first occurrence is
likely as a unique cis eQTLs that can either disappear completely
or more likely as we increase sample size becomes common to a
Figure 2. Single tissue analysis of cis eQTLs. a) Percentage overlaps between cis eQTLs detected in 2 consecutive sub samples. Approximately
90% of the cis eQTLs are found in common between consecutive sub samples. b) Percentage overlap between the cis eQTLs detected in a sub
sample and the set of cis eQTLs detected in sample N20. As in panel a) we see more than 90% overlap between the cis eQTLs in any sub sample and
the ones identified in the largest sample. c) Percentage of the cis eQTLs identified in N20 represented in each sub sample. This plot is complementary
to the plot in panel (b) the reference in this plot is the set of cis eQTLs detected in N20. While indeed 90% of cis eQTLs from smallest sub sample are
recovered in the largest sub sample (b) they only represent about 10% of all cis eQTLs detected in N20. In panels d–f we plot the same quantities as in
a–c but for the eSNPs. The set of eSNPs overlap at a rate of 80% between consecutive steps of the analysis as seen in panel d. e) In contrast to the
high degree (,90%) of overlap between cis eQTLs detected in any sub samples and the set of cis eQTLs in N20 we see that replication for eSNPs is
strongly affected by sample size, increasing from ,50% to ,80%. f) Relative to the eSNPs identified in N20 we see a lower overlapping rate in sub
samples than cis eQTLs.
doi:10.1371/journal.pone.0023480.g002
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order to obtain a qualitative description of the cis eQTL dynamics
we introduced four rates relative to change in sample size between
consecutive steps: creation rate defined as the number of new cis
eQTLs identified between steps (also not identified in any tissue in
a previous step), deletion rate defined as the number of cis eQTLs
lost between consecutive steps (no longer detected in any tissue),
move OUT rate defined as the number of cis eQTLs detected in a
particular combination of tissues that don’t satisfy the requirement
anymore and move IN rate, that is the opposite to move OUT rate
and describes the dynamic of cis eQTLs that now satisfy a new
requirement. In Figure 3b–e we plot these rates for cis eQTLs
identified in OA tissue (similar results were observed for all 3
tissues), for the set of cis eQTLs detected in all 3 tissues (Figure 3b),
unique to OA (Figure 3c), detected in both OA-SA (Figure 3d) and
detected in both liver-OA (Figure 3e). The set of cis eQTLs
common to all 3 tissues (Figure 3b) have a zero creation rate,
indicating that a cis eQTL has to be detected first in a tissue then
detected in a pair of tissues before becomes detected in all 3 tissues,
zero deletion rate indicating that these cis eQTLs were detected in
at least one tissue at a prior step, and a move IN rate ,46larger
than move OUT rate, indicating a further accumulation of cis
eQTLs common to all 3 tissues as we increase sample size. Unique
cis eQTLs detected in OA tissue display the largest creation rate,
and a very small move IN rate. The plateauing observed in
Figure 1b for the number of unique cis eQTLs in OA correlates
with the fact that overall creation rate approximates the sum of
deletion and move OUT rates (the move IN rate is negligible) that
leads to an overall unchanged number of unique cis eQTLs but
with a different composition in the set. As with cis eQTLs common
to all 3 tissues the ones common to a pair of tissues (Figure 4d–e)
have approximate zero deletion rate, however move IN and move
OUT rates are becoming close in value as we increase sample size
that again signals a plateauing in their numbers as observed in
Figure 1b. Looking at similar quantities as in Figure 2a, in
consecutive steps we see an almost 100% overlap between cis
Figure 3. Cis eQTLs dynamics in the context of sample size for OA cis eQTLs. a) Cis eQTL overlaps (rows) in each sub sample (columns). If
A,B,C represent OA, SA and liver, the color legend represents 7 classes of cis eQTLs as follows: red unique to OA, black unique to SA, green unique to
liver, blue detected in both OA-SA, magenta detected in both SA-liver, turquoise detected in both liver-OA, grey common to all 3 tissues, white not
detected in the analysis. We observe that new cis eQTLs at each step are first detected as nonoverlapping, specific to a tissue, while the majority of
common cis eQTLs were previously detected in at least one tissue. Tuns as a function of sample size, a cis eQTLs will be first detected as unique to a
tissue, than as sample size increases it will become detected in a pair of tissue or becoming common to all 3 tissues. b–e) Rate of change defined as
change in number of cis eQTLs relative to change in sample size. We plot define four rates, relative to change in sample size: creation (green) defined
as the number of new (not identified in a previous step in any tissue) cis eQTLs; deletion (red) defined as the number of cis eQTLs not detected in any
tissue anymore from a previous step; move OUT (blue) defined as the number of cis eQTLs that do not satisfy the detection requirement of the class
anymore; move IN (black) defined as the number of cis eQTLs that now satisfy the detection requirement of the class. b) cis eQTLs common to all 3
tissues have null creation and deletion rates indicating that a cis eQTL becomes common to all 3 tissues only if it was detected in a previous step. c)
Unique to OA cis eQTLs have small move IN rates, with large creation rate. As sample size increases the creation rate approximates the sum of move
OUT and deletion rates. Both partially overlapping cis eQTLs in OA-SA d) or liver-OA e) have approximate zero deletion and creation rates, with move
IN rate larger that move OUT rate, the difference between these 2 rates becoming smaller as we increase the sample size.
doi:10.1371/journal.pone.0023480.g003
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eQTLs in OA or SA and 80% overlap for cis eQTLs in liver
(Figure S2).
eSNPs have not been identified for every known transcript or
different transcript isoform, and beyond tissue specific expression it
is not known why an eSNP present in one tissue (cell type) may not
be detected in another tissue. We performed gene ontology
analysis on the tissue specific eQTLs and the ubiquitous (found in
many tissues) eQTLs to determine if we could identify any relevant
biology specific to each of the eQTL subsets (Figure 4c). We note
that the cohort used in the present study was predominantly
morbidly obese subjects, which may affect both the anatomical
and physiological state of the adipose tissue and the liver. Using
Gene Ontology Biological Processes (GOBP) we find that the
ubiquitous eQTL subset was enriched for oxidative reduction
(FET p=3610
210) and antigen processing and presentation (FET
p=3.4610
210). eQTLs found in both OA and SA where enriched
for cell-cell adhesion (FET p=2.3610
25) and glycosphingolipid
biosynthetic processes (FET p=0.00043). This is of interest given
the extreme obesity of the study populations. These pathways have
been associated with adipose tissue remodeling, vascularization
and metabolism (mainly insulin sensitivity) through changes in
body weight [18,19]. Liver specific eQTLs were enriched for
regulation of response to stimulus (FET p=0.00017) and blood
coagulation (FET p=0.00078), while SA specific eQTLs were
enriched for metal ion transport (FET p=0.00029) and feeding
behavior (FET p=0.00042). OA specific eQTLs were enriched for
cell-cell adhesion (FET p=6.3610
25). The gene ontologies
identified for eQTLs from a given tissue, without taking into
account tissue specificity were more representative of tissue type,
for example liver eQTLs were found to be enriched for lipid
metabolic process (FET p=1.5610
27).
Discussion
Using sub-samples from a cohort of obese individuals that
underwent RYGB we were able to derive scaling laws for the
number of cis eQTLs detected as a function of sample size in three
tissues. We show that saturation for eSNP identification in the
largest population analyzed was not achieved. We predict that
given a sufficiently large population it is likely that for each
transcript and transcript isoform variation we will be able to
Figure 4. Gene Ontology (GO) enrichment for cis eQTLs. a) Heat map for GO Biological Processes terms that exceed FET p value 10
23 in the
largest samples throughout the sub-sampling process. We see that p values decrease as sample size increases with a large jump from the 20
th sample
to the largest sample. b) Cis eQTL replication in published studies. We observe an extreme large replication of published data in each of the tissues
analyzed. Although published data does not replicate in the tissue specific cis eQTLs, we see a large overlap with the common cis eQTLs replicated in
all the tissues in out analysis. c) Sacked bar-plot of {log10(p) for a subset of GOBP terms using the largest samples. In terms of GO enrichment we see
several terms that are enriched in each tissues individually as well as in the intersection. Liver cis eQTLs are also uniquely enriched for lipid processes
as well as for immune response terms.
doi:10.1371/journal.pone.0023480.g004
Cis Regulation of Gene Expression in Humans
PLoS ONE | www.plosone.org 6 August 2011 | Volume 6 | Issue 8 | e23480identify a corresponding regulatory variant (eSNP). Such a
behavior is observed for the cis eQTLs overlapping all three
tissues. In contrast, the cis eQTLs that overlap any two pairs of
tissues or are unique to a tissue as they start to saturate for a given
sample size. However the saturation seems to be on different scales
in the two-tissue overlaps versus single tissue-specific cases. Overall
we show that while there is no apparent slow down in the number
of cis eQTLs detected in each tissue we observed that the detection
of unique cis eQTLs for each tissue or found in pairs of tissues can
be achieved much sooner.
As a dynamic quantity the cis eQTLs can become very stable if
it becomes common to all 3 tissues, i.e. these cis eQTLs have zero
deletion and creation rates. In contrast, unique cis eQTLs are the
most unstable, dominated by a very high false discovery rate,
,40% of unique cis eQTLs in OA or SA are lost in consecutive
steps. Creation, destruction, move IN and move OUT rates
explain the plateauing in the number of partially overlapping and
unique cis eQTLs and the continuous rise in the number of
common cis eQTLs. A key element in the analysis is tissue type.
The two related tissues (OA and SA) share more cis eQTLs, with a
weaker overlap with liver. The similarity between OA and SA
tissues is responsible for the very large set of cis eQTLs found in
common to both these tissues (that excludes cis eQTLs common to
all 3 tissues).
Gene set analysis and replication efforts in existing studies help
us understand and hypothesize the molecular mechanisms
represented by different sets of eSNPs. cis eQTLs identified in
all 3 tissues in our analysis prove to be the most stable, as the
majority of them have been now replicated in four different studies
[6,20,21,22]. Unique cis eQTLs show a weak replication and also
weak GO enrichment, possibly due to large false positive rates.
The changes in enrichment with the increase in sample size did
not provide additional information.
Materials and Methods
Data set description
Detailed information about the sample collection and data
generation can be found here [1]. Briefly, tissues were collected
from patients at the time of RYGB surgery at Massachusetts
General Hospital between 2000 and 2007 as described previously
[1]. Genomic DNA was extracted from liver tissues, total RNA
was extracted from liver, SA and OA. RNA was converted to
fluorescently labeled cRNA that was hybridized to custom 44K
DNA oligonucleotide microarrays manufactured by Agilent
Technologies as described previously [2,23]. The custom array
consists of 4,720 control probes and 39,820 non control
oligonucleotides. Each DNA sample was genotyped on the
Illumina 650Y BeadChip array. Sex was confirmed using PLINK
[24]. Identity by state (IBS) analysis was performed to identify
related individuals. Eighteen parent-offspring, 6 sibling and
8 second degree relatives were identified, 4 of these were related
trios. 28 individuals were removed to eliminate IBS in the dataset.
393 subjects, which are self-reported Caucasians, were included in
our analysis for which genotyping and gene expression data was
available from all three tissues.
Demographic information including age, race, gender, height,
type of surgery and year of surgery were collected for each patient.
The cohort was predominantly (88%) self reported ‘white’ and
female (75%).
Microarray Data
The expression data is publicly available at GEO super series
Accession ID GSE24335 and was previously described in [1]. All
microarray data utilized in this study is MIAME compliant.
Genotyping data is available at dbGAP (https://dbgap.ncbi.nlm.
nih.gov/) and all data is available upon request from Massachu-
setts General Hospital at http://www.samscores.org.
eSNP identification
Cis and trans acting expression quantitative trait loci (eQTLs)
were identified using a method similar to that previously described
[3]. Briefly, eQTLs for gene expression traits were determined by
identifying the SNP most strongly associated with each expression
trait profiled on the array over all genotyped SNPs. A cis eQTL
occurs if the SNP and the transcript are within 1 Mb from each
other regardless of the transcriptional start or stop of the
transcript. All other eQTLs that are not cis- are trans-eQTLs.
Association was tested to all expression traits measured on the
array. Only associations that exceed 10% FDR are reported. FDR
was estimated by permuting expression data.
Supporting Information
Figure S1 eSNP and eQTL numbers as function of
sample size. In panels a) and b) we show the eSNPs as function
of sample size in the log-normal space a) and linear space b);
similar plot for the number of cis eQTLs in panels c) and d). The
plateauing in the number of cis eQTLs partially overlapping and
nonoverlapping can be much easier observed. Clearly only the
number of cis eQTLs common to all 3 tissues is increasing as
function of sample size.
(TIF)
Figure S2 Slope for the number of cis eQTLs. Slope is
calculated using a window of a) 10 consecutive points and b)1 5
consecutive points. In order to assess the changes in the cis eQTL
numbers vs. sample size in log-normal space (Figure 1b and Figure
S1c, d) we compute slope in a window containing 10 or 15
consecutive points. We see that slope is increasing for cis eQTLs
overlapping in all 3 tissues, with the rate of identifying non-
overlapping cis eQTLs shows a decrease as we increase sample
size.
(TIF)
Figure S3 Detailed plots for cis eQTL analysis. Similar to
Figure 2a–c we plot in panel a) for each set of cis eQTLs between
rate of conservation between consecutive steps, panel b) rate of
overlap to cis eQTLs found in the largest sub sample and panel c)
rate of overlap between cis eQTLs identified in the largest sub
sample and cis eQTLs detected in the 20 consecutive sub-samples.
Cis eQTLs common to all 3 tissues shows an almost 100% rate
overlap between consecutive steps. Cis eQTLs unique to liver
show a higher overlapping rate compared to cis eQTLs unique to
OA or SA which we believe is due to tissue similarity. Similarly, cis
eQTLs overlapping between OA and SA show a higher rate
compared to any other pair of tissues.
(TIF)
Figure S4 Box-plots for SNP-trait distance in log10
space. With red we marked overlapping cis eQTLs and white
unique cis eQTLs in: a) OA, b) SA and c) liver. The reason we
show distance log10 transformed is due to the asymmetry of its
distribution (heavily shifted to the left). Since the logarithm is a
monotonic function the values for any non-parametric test remain
unchanged. For each data point the p values for a parametric or
non-parametric test between the groups yields values very close to
0 (the largest p value ,10
260).
(TIF)
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ple series. Total number of cis eQTLs in a) OA, b) SA and c)
liver obtain in 5 different random realizations of the sub sample
series. For 4 of the series we identified cis eQTLs in only the first
10 sub samples. The last data point is the total number of cis
eQTLs detected with the largest sample available. We see that
overall the inferred scaling laws are unchanged for any series.
(TIF)
Figure S6 Sample specific eSNPs associated with
ADRA2B and ARNTL. We show an example 2 cis eQTLs,
panel a) ADRA2B in omental adipose, and panel b) ARNT in liver,
that are associated with different eSNPs while increasing sub
sample size. On the positive side of the y axis we indicate the eSNP
position and its strength of the association -log10(p) in each sub
sample i (i.e. i takes values from 1 to 20, with i=21 represents the
eSNP generated in the largest sample), and the negative y axis are
the log10(p) for the KW test between the expression levels of the
transcript and all the SNPs in the window using the largest sample
available for each tissue. The genomic position is represented on
Mb scale on the x axis. We show the transcript position using the
orange bar. We can see that as more genetic information is
available from the increase in sample size the position of the cis
lead eSNP changes. We also show the LD structure (R
2) for that
window below, data obtained from HapMap phase 2 and 3 release
27.
(TIF)
Table S1 Sample sizes and SNP summary. Sample sizes
for all 20 sub samples together with the SNPs that did not pass a
5% MAF. The 2 additional columns show the sample size in log-
normal space, and delta the difference between 2 consecutive
samples sizes in log-normal space.
(TIF)
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